The UCLA Advanced Heart Failure Program is comprised of an expert team of cardiologists with specialized training and expertise in managing the complexities of heart failure. The Ahmanson-UCLA Cardiomyopathy Center and UCLA Heart Transplant Center have led the way over the past two decades to develop new medical therapies, devices and disease-management strategies for heart failure. These advances significantly improve quality of life for patients, reduce their risk for hospitalization and improve their chances for survival.
As advanced heart failure can have a wide variety of causes, such as genetic mutations and congenital heart disease, and often has concomitant issues such as arrhythmias, our team works in close collaboration with cardiologists from a variety of programs. Additionally, our comprehensive program offers advanced therapies that include mechanical circulatory support and heart transplantation.
For more information about our wide breadth of programs, please browse through the links below:
New cardiac revascularization program aimed at high-risk patients (PDF)
New cardiac revascularization program aimed at high-risk patients (PDF)
Device treats patients with mitral valve disease who are not candidates for open-heart surgery (PDF)
Implanted pressure monitoring device improves heart-failure management and outcomes (PDF)
